rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1996-4-11
|
pubmed:abstractText |
Patients with acute proximal deep-vein thrombosis are usually treated first in the hospital with intravenous standard (unfractionated) heparin. However, the longer plasma half-life, better bioavailability after subcutaneous administration, and more predictable anticoagulant response of low-molecular-weight heparins make them attractive for possible home use. We compared these two approaches.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
334
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
677-81
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8594425-Aged,
pubmed-meshheading:8594425-Anticoagulants,
pubmed-meshheading:8594425-Enoxaparin,
pubmed-meshheading:8594425-Female,
pubmed-meshheading:8594425-Hemorrhage,
pubmed-meshheading:8594425-Heparin,
pubmed-meshheading:8594425-Home Nursing,
pubmed-meshheading:8594425-Hospitalization,
pubmed-meshheading:8594425-Humans,
pubmed-meshheading:8594425-Infusions, Intravenous,
pubmed-meshheading:8594425-Injections, Subcutaneous,
pubmed-meshheading:8594425-Male,
pubmed-meshheading:8594425-Middle Aged,
pubmed-meshheading:8594425-Popliteal Vein,
pubmed-meshheading:8594425-Recurrence,
pubmed-meshheading:8594425-Self Administration,
pubmed-meshheading:8594425-Thromboembolism,
pubmed-meshheading:8594425-Thrombosis,
pubmed-meshheading:8594425-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
|
pubmed:affiliation |
McMaster University, Hamilton, Ont., Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|